These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3488778)

  • 1. Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlation.
    Bertram JH; Gill PS; Levine AM; Boquiren D; Hoffman FM; Meyer P; Mitchell MS
    Blood; 1986 Sep; 68(3):752-61. PubMed ID: 3488778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of in vitro and in vivo antigenic modulation by the anti-human T-cell monoclonal antibody T101.
    Shawler DL; Miceli MC; Wormsley SB; Royston I; Dillman RO
    Cancer Res; 1984 Dec; 44(12 Pt 1):5921-7. PubMed ID: 6333922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of T101 monoclonal antibody in chronic lymphocytic leukemia and cutaneous T-cell lymphoma.
    Dillman RO; Beauregard J; Shawler DL; Halpern SE; Markman M; Ryan KP; Baird SM; Clutter M
    J Biol Response Mod; 1986 Oct; 5(5):394-410. PubMed ID: 3490543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.
    Foss FM; Raubitscheck A; Mulshine JL; Fleisher TA; Reynolds JC; Paik CH; Neumann RD; Boland C; Perentesis P; Brown MR; Frincke JM; Lollo CP; Larson SM; Carrasquillo JA
    Clin Cancer Res; 1998 Nov; 4(11):2691-700. PubMed ID: 9829731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution and serum kinetics of T101 monoclonal antibody during passive anti-cancer therapy.
    Shawler DL; Beauregard J; Halpern SE; Baird SM; Dillman RO
    Clin Immunol Immunopathol; 1986 Oct; 41(1):43-54. PubMed ID: 3488861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T65 antigen modulation in a phase I monoclonal antibody trial with chronic lymphocytic leukemia patients.
    Schroff RW; Farrell MM; Klein RA; Oldham RK; Foon KA
    J Immunol; 1984 Sep; 133(3):1641-8. PubMed ID: 6379051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic modulation by anti-CD5 immunotoxins.
    Manske JM; Buchsbaum DJ; Azemove SM; Hanna DE; Vallera DA
    J Immunol; 1986 Jun; 136(12):4721-8. PubMed ID: 3086441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term persistence of human anti-murine antibody responses following radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphoma patients using 131I-T101.
    Goldman-Leikin RE; Kaplan EH; Zimmer AM; Kazikiewicz J; Manzel LJ; Rosen ST
    Exp Hematol; 1988 Nov; 16(10):861-4. PubMed ID: 3262528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immune response to multiple injections of murine monoclonal IgG.
    Shawler DL; Bartholomew RM; Smith LM; Dillman RO
    J Immunol; 1985 Aug; 135(2):1530-5. PubMed ID: 3874237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of human CD5 modulation and capping induced by murine monoclonal antibody T101.
    Shawler DL; Johnson DE; McCallister TJ; Bartholomew RM; Dillman RO
    Clin Immunol Immunopathol; 1988 May; 47(2):219-29. PubMed ID: 3258212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective cytotoxicity of 125I-labeled monoclonal antibody T101 in human malignant T cell lines.
    Boven E; Lindmo T; Mitchell JB; Bunn PA
    Blood; 1986 Feb; 67(2):429-35. PubMed ID: 2417645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study.
    Rosen ST; Zimmer AM; Goldman-Leikin R; Gordon LI; Kazikiewicz JM; Kaplan EH; Variakojis D; Marder RJ; Dykewicz MS; Piergies A
    J Clin Oncol; 1987 Apr; 5(4):562-73. PubMed ID: 3549989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.
    Maloney DG; Grillo-López AJ; White CA; Bodkin D; Schilder RJ; Neidhart JA; Janakiraman N; Foon KA; Liles TM; Dallaire BK; Wey K; Royston I; Davis T; Levy R
    Blood; 1997 Sep; 90(6):2188-95. PubMed ID: 9310469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased density of ecto 5' nucleotidase antigen on leukemic T cells from patients with cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
    Fukunaga Y; Evans SS; Yamamoto M; Ueda Y; Tamura K; Takakuwa T; Gebhard D; Allopenna J; Demaria S; Clarkson B
    Blood; 1989 Nov; 74(7):2486-92. PubMed ID: 2553165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody.
    Dillman RO; Shawler DL; Dillman JB; Royston I
    J Clin Oncol; 1984 Aug; 2(8):881-91. PubMed ID: 6379121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of multiple T cell-directed intact ricin immunotoxins for autologous bone marrow transplantation.
    Stong RC; Uckun F; Youle RJ; Kersey JH; Vallera DA
    Blood; 1985 Sep; 66(3):627-35. PubMed ID: 3896347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing effects of monocytes on modulation of a lymphocyte membrane antigen.
    Schroff RW; Klein RA; Farrell MM; Stevenson HC
    J Immunol; 1984 Oct; 133(4):2270-7. PubMed ID: 6236264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of therapy with T101 ricin A-chain immunotoxin in two leukemia patients.
    Laurent G; Pris J; Farcet JP; Carayon P; Blythman H; Casellas P; Poncelet P; Jansen FK
    Blood; 1986 Jun; 67(6):1680-7. PubMed ID: 3085747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging and dosimetry determinations using radiolabeled antibodies.
    Carrasquillo J
    Cancer Treat Res; 1993; 68():65-97. PubMed ID: 8105853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.